150 related articles for article (PubMed ID: 2686707)
1. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
[TBL] [Abstract][Full Text] [Related]
2. Activated conformations of the ras-gene-encoded p21 protein. 1. An energy-refined structure for the normal p21 protein complexed with GDP.
Dykes DC; Brandt-Rauf P; Luster SM; Chung D; Friedman FK; Pincus MR
J Biomol Struct Dyn; 1992 Jun; 9(6):1025-44. PubMed ID: 1637501
[TBL] [Abstract][Full Text] [Related]
3. Activated conformations of the ras-gene-encoded p21 protein. 2. Comparison of the computed and high-resolution x-ray crystallographic structures of Gly-12 p21.
Dykes DC; Brandt-Rauf P; Luster SM; Friedman FK; Pincus MR
J Biomol Struct Dyn; 1993 Apr; 10(5):905-18. PubMed ID: 8318164
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
Chen JM; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.
Liwo A; Gibson KD; Scheraga HA; Brandt-Rauf PW; Monaco R; Pincus MR
J Protein Chem; 1994 Feb; 13(2):237-51. PubMed ID: 8060496
[TBL] [Abstract][Full Text] [Related]
6. Conformations of the central transforming region (Ile 55-Met 67) of the p21 protein and their relationship to activation of the protein.
Chen JM; Lee G; Brandt-Rauf PW; Murphy RB; Gibson KD; Scheraga HA; Rackovsky S; Pincus MR
Int J Pept Protein Res; 1990 Sep; 36(3):247-54. PubMed ID: 2279848
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics of the H-ras gene-encoded p21 protein; identification of flexible regions and possible effector domains.
Dykes DC; Friedman FK; Dykes SL; Murphy RB; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1993 Dec; 11(3):443-58. PubMed ID: 8129867
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the predicted structures of loops in the ras-SOS protein bound to a single ras-p21 protein with the crystallographically determined structures in SOS bound to two ras-p21 proteins.
Smith S; Hyde M; Pincus MR
Protein J; 2005 Aug; 24(6):391-8. PubMed ID: 16323045
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein.
Monaco R; Chen JM; Chung D; Brandt-Rauf P; Pincus MR
J Protein Chem; 1995 Aug; 14(6):457-66. PubMed ID: 8593186
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
Tong LA; de Vos AM; Milburn MV; Kim SH
J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of intact elongation factor EF-Tu from Escherichia coli in GDP conformation at 2.05 A resolution.
Song H; Parsons MR; Rowsell S; Leonard G; Phillips SE
J Mol Biol; 1999 Jan; 285(3):1245-56. PubMed ID: 9918724
[TBL] [Abstract][Full Text] [Related]
12. Structural differences between a ras oncogene protein and the normal protein.
Tong LA; de Vos AM; Milburn MV; Jancarik J; Noguchi S; Nishimura S; Miura K; Ohtsuka E; Kim SH
Nature; 1989 Jan; 337(6202):90-3. PubMed ID: 2642607
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of p21 ras proteins.
Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
[TBL] [Abstract][Full Text] [Related]
14. Ligand-induced conformational changes in ras p21: a normal mode and energy minimization analysis.
Ma J; Karplus M
J Mol Biol; 1997 Nov; 274(1):114-31. PubMed ID: 9398520
[TBL] [Abstract][Full Text] [Related]
15. Genetic and biochemical analysis of ras p21 structure.
McCormick F; Levenson C; Cole G; Innis M; Clark R
Symp Fundam Cancer Res; 1986; 39():137-42. PubMed ID: 3321304
[TBL] [Abstract][Full Text] [Related]
16. Family of G protein alpha chains: amphipathic analysis and predicted structure of functional domains.
Masters SB; Stroud RM; Bourne HR
Protein Eng; 1986; 1(1):47-54. PubMed ID: 3148932
[TBL] [Abstract][Full Text] [Related]
17. Pathways for activation of the ras-oncogene-encoded p21 protein.
Pincus MR; Chung D; Dykes DC; Brandt-Rauf P; Weinstein IB; Yamaizumi Z; Nishimura S
Ann Clin Lab Sci; 1992; 22(5):323-42. PubMed ID: 1524403
[TBL] [Abstract][Full Text] [Related]
18. Probing the role of the C-H...O hydrogen bond stabilized polypeptide chain reversal at the C-terminus of designed peptide helices. Structural characterization of three decapeptides.
Aravinda S; Shamala N; Bandyopadhyay A; Balaram P
J Am Chem Soc; 2003 Dec; 125(49):15065-75. PubMed ID: 14653741
[TBL] [Abstract][Full Text] [Related]
19. Regional homology in GTP-binding proto-oncogene products and elongation factors.
Halliday KR
J Cyclic Nucleotide Protein Phosphor Res; 1983-1984; 9(6):435-48. PubMed ID: 6396323
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.
Krengel U; Schlichting I; Scherer A; Schumann R; Frech M; John J; Kabsch W; Pai EF; Wittinghofer A
Cell; 1990 Aug; 62(3):539-48. PubMed ID: 2199064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
